Pharmaceutical Technology | Drug Development News & Views Updated Daily

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Advertise with us

EUSA Pharma to acquire Janssen Ireland’s Sylvant for $115m

EUSA Pharma has signed a definitive agreement to purchase global rights for Sylvant (siltuximab) drug...
Read More...

EUSA Pharma to acquire Janssen Ireland’s Sylvant for $115m

Supporting mental health in a business environment

Download a free 10 page preview of our Mergers & Acquisitions in TMT – Thematic Research 2019 Report